Barbiturates and pyrazolopyridines for the treatment of postpartum depression-repurposing of two drug classes

• Asıl Yazarlar: Alexander B. Horwitz (Yazar), Robert T. Rubin (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Zulresso (brexanolone) is an aqueous formulation of the neurosteroid, allopregnanolone, and the only FDA-approved medication for the treatment of postpartum depression (PPD). While brexanolone is effective for the treatment of PPD, lengthy infusion time and high cost can be prohibitive. Failure of G...